{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:39:47Z","timestamp":1793813987808,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["397973"],"award-info":[{"award-number":["397973"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.lana.2022.100271","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T06:29:21Z","timestamp":1652250561000},"page":"100271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["A scoping review of opioid harm reduction interventions for equity-deserving populations"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4761-589X","authenticated-orcid":false,"given":"Katrina","family":"Milaney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Haines-Saah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenlea","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun","family":"Egunsola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Mastikhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sage","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Lorenzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3162-4329","authenticated-orcid":false,"given":"Brian","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"McBrien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Rittenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"O'Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Doig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Cabaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Stokvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lana.2022.100271_bib0001","first-page":"343","article-title":"Facing up to the prescription opioid crisis","author":"Dhalla","year":"2011","journal-title":"BMJ"},{"issue":"S1","key":"10.1016\/j.lana.2022.100271_bib0002","first-page":"S199","article-title":"Revisiting the \u2018paradigm shift\u2019 in opioid use: Developments and implications 10 years later","volume":"37","author":"Fischer","year":"2017","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.lana.2022.100271_bib0003","article-title":"Sexual orientation and estimates of adult substance use and mental health: results from the 2015 national survey on drug use and health","author":"Medley","year":"2016","journal-title":"NSDUH Data Rev"},{"issue":"11","key":"10.1016\/j.lana.2022.100271_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15638","article-title":"Association of disability with mortality from opioid overdose among US Medicare adults","volume":"2","author":"Kuo","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.lana.2022.100271_bib0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.24095\/hpcdp.38.6.02","article-title":"The opioid crisis in Canada: a national perspective","volume":"38","author":"Belzak","year":"2018","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"10.1016\/j.lana.2022.100271_bib0006","unstructured":"Opioids and substances of misuse among first nations people in Alberta: Alberta report (Alberta Health) (2017)."},{"issue":"8","key":"10.1016\/j.lana.2022.100271_bib0007","article-title":"Equity-oriented frameworks to inform responses to opioid overdoses: a scoping review","volume":"19","author":"Wallace","year":"2021","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.lana.2022.100271_bib0008","first-page":"78","volume":"201","author":"Schuler","year":"2019","journal-title":"Sexual minority disparities in opioid misuse, perceived heroin risk and heroin access among a national sample of US adults"},{"key":"10.1016\/j.lana.2022.100271_bib0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/epirev\/mxh007","article-title":"The social epidemiology of substance use","volume":"26","author":"Galea","year":"2004","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.lana.2022.100271_bib0010","unstructured":"Harm Reduction International. What is harm reduction? 2022, https:\/\/www.hri.global\/what-is-harm-reduction"},{"issue":"3","key":"10.1016\/j.lana.2022.100271_bib0011","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/09581590500372188","article-title":"Harm reduction as paradigm: is better than bad good enough? The origins of harm reduction","volume":"15","author":"Roe","year":"2005","journal-title":"Crit Public Health"},{"issue":"1","key":"10.1016\/j.lana.2022.100271_bib0012","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","article-title":"Harm reduction principles for healthcare settings","volume":"14","author":"Hawk","year":"2017","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.lana.2022.100271_bib0013","series-title":"Inspiring Inclusive Excellence \u2013 Professor Wisdom Tettey's Installation Address","author":"Tettey","year":"2019"},{"issue":"7","key":"10.1016\/j.lana.2022.100271_bib0014","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.lana.2022.100271_bib0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13643-016-0204-x","article-title":"What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products","volume":"5","author":"Miake-Lye","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.lana.2022.100271_bib0016","article-title":"Employment equity act (S.C. 1995, c. 44)","volume":"44","year":"1995","journal-title":"Government of Canada"},{"issue":"1","key":"10.1016\/j.lana.2022.100271_bib0017","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12905-021-01196-6","article-title":"Women's multiple uses of an overdose prevention technology to mitigate risks and harms within a supportive housing environment: a qualitative study","volume":"21","author":"Bardwell","year":"2021","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1016\/j.lana.2022.100271_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03630242.2019.1610829","article-title":"Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment","volume":"60","author":"Jancaitis","year":"2020","journal-title":"Women Health"},{"issue":"2","key":"10.1016\/j.lana.2022.100271_bib0019","doi-asserted-by":"crossref","first-page":"e18296","DOI":"10.2196\/18296","article-title":"Identifying self-management support needs for pregnant women with opioid misuse in online health communities: mixed methods analysis of web posts","volume":"23","author":"Liang","year":"2021","journal-title":"J Med Internet Res"},{"issue":"1","key":"10.1016\/j.lana.2022.100271_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13011-021-00360-3","article-title":"They're not doing enough\": women's experiences with opioids and naloxone in Toronto","volume":"16","author":"Macleod","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"10.1016\/j.lana.2022.100271_bib0021","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/add.14825","article-title":"Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery","volume":"115","author":"Nielsen","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.lana.2022.100271_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106529","article-title":"A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: results from a pilot study","volume":"110","author":"Park","year":"2020","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.lana.2022.100271_bib0023","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/ADM.0000000000000534","article-title":"Continuation in treatment and maintenance of custody of newborns after delivery in women with opioid use disorder","volume":"14","author":"Schauberger","year":"2020","journal-title":"J Addict Med"},{"issue":"2","key":"10.1016\/j.lana.2022.100271_bib0024","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.lana.2022.100271_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12913-021-06182-0","article-title":"Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment","volume":"21","author":"Titus-Glover","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"10.1016\/j.lana.2022.100271_bib0026","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2012.08.027","article-title":"A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans","volume":"128","author":"Mitchell","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.lana.2022.100271_bib0027","first-page":"160","article-title":"Community-wide measures of wellness in a remote first nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a first nations healing program","volume":"61","author":"Kanate","year":"2015","journal-title":"Can Fam Phys"},{"issue":"3","key":"10.1016\/j.lana.2022.100271_bib0028","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.9778\/cmajo.20150076","article-title":"Impact of a methadone maintenance program on an aboriginal community: a qualitative study","volume":"4","author":"Landry","year":"2016","journal-title":"CMAJ Open"},{"issue":"2","key":"10.1016\/j.lana.2022.100271_bib0029","first-page":"137","article-title":"Evaluation of 6 remote first nations community-based buprenorphine programs in northwestern Ontario: retrospective study","volume":"63","author":"Mamakwa","year":"2017","journal-title":"Can Fam Physician"},{"issue":"2","key":"10.1016\/j.lana.2022.100271_bib0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/02791072.2015.1014948","article-title":"Changes in quality of life following buprenorphine treatment: relationship with treatment retention and illicit opioid use","volume":"47","author":"Mitchell","year":"2015","journal-title":"J Psychoact Drugs"},{"issue":"2","key":"10.1016\/j.lana.2022.100271_bib0031","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/08897077.2018.1547810","article-title":"Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic","volume":"40","author":"Lister","year":"2019","journal-title":"Subst Abus"},{"key":"10.1016\/j.lana.2022.100271_bib0032","year":"2016","journal-title":"Opiod agonist therapy"},{"key":"10.1016\/j.lana.2022.100271_bib0033","unstructured":"Public Health Ontario. Interventions for opioid agonist treatment access among harm reduction clients. 2019. https:\/\/www.publichealthontario.ca\/-\/media\/documents\/rapid-review-opioid-agonist-treatment.pdf?la=en"},{"key":"10.1016\/j.lana.2022.100271_bib0034","unstructured":"Canadian Research Initiative in Substance Misuse. CRISM National guideline for the clinical management of opioid use disorder.2018. https:\/\/crism.ca\/wp-content\/uploads\/2018\/03\/CRISM_NationalGuideline_OUD-ENG.pdf"},{"key":"10.1016\/j.lana.2022.100271_bib0035","first-page":"419","article-title":"Overmedicalization of pregnancy and childbirth","volume":"7","author":"Ranjbar","year":"2017","journal-title":"Int J Women's Health Reproduct Sci"},{"issue":"2","key":"10.1016\/j.lana.2022.100271_bib0036","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: no easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.lana.2022.100271_bib0037","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12954-021-00507-2","article-title":"Organizational support for frontline harm reduction and systems navigation work among workers with living and lived experience: qualitative findings from British Columbia, Canada","volume":"18","author":"Greer","year":"2021","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.lana.2022.100271_bib0038","series-title":"\u201cNothing about Us Without Us\u201d: Greater, Meaningful Involvement of People Who Use Illegal Drugs: A Public Health, Ethical, and Human Rights Imperative","year":"2006"},{"key":"10.1016\/j.lana.2022.100271_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112384","article-title":"The intersectional risk environment of people who use drugs","volume":"234","author":"Collins","year":"2019","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.lana.2022.100271_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102733","article-title":"Bed bugs and beyond: an ethnographic analysis of North America's first women-only supervised drug consumption site","volume":"78","author":"Boyd","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"4","key":"10.1016\/j.lana.2022.100271_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060600","article-title":"Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada","volume":"8","author":"Madadi","year":"2013","journal-title":"Plos One"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X22000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X22000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:16:01Z","timestamp":1778930161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X22000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":41,"alternative-id":["S2667193X22000886"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2022.100271","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A scoping review of opioid harm reduction interventions for equity-deserving populations","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2022.100271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100271"}}